Document Detail


Recent advances with chemotherapy for NSCLC: the ECOG experience. Eastern Cooperative Oncology Group.
MedLine Citation:
PMID:  9516615     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Management of disseminated non-small-cell lung cancer has changed over the past 10 years. Newer agents, such as vinorelbine (Navelbine) and paclitaxel (Taxol), have been shown to modestly improve survival in patients with advanced disease when administered in conjunction with cisplatin (Platinol). Compared with older regimens consisting of cisplatin and a Vinca alkaloid or a podophyllotoxin, the newer regimens yield a 10- to 15-week improvement in median survival and an additional 10% to 15% in 1-year survival. Based on these results derived from randomized trials, it appears that metastatic non-small-cell lung cancer patients with good performance status should be treated with regimens containing either vinorelbine or paclitaxel in conjunction with cisplatin.
Authors:
D H Johnson; A Y Chang; D S Ettinger; K M Kim; P Bonomi
Related Documents :
12648575 - Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecolo...
9007135 - Paclitaxel and simultaneous radiation in the treatment of stage iiia/b non-small cell l...
10573115 - Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phas...
9829735 - Superiority of sequential versus concurrent administration of paclitaxel with etoposide...
7631025 - Epidermoid carcinoma of the anal margin: 17 cases treated with curative-intent radiatio...
17046745 - Evaluation of topical external medicine for 5-fluorouracil-induced oral mucositis in ha...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Oncology (Williston Park, N.Y.)     Volume:  12     ISSN:  0890-9091     ISO Abbreviation:  Oncology (Williston Park, N.Y.)     Publication Date:  1998 Jan 
Date Detail:
Created Date:  1998-05-14     Completed Date:  1998-05-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8712059     Medline TA:  Oncology (Williston Park)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  67-70     Citation Subset:  IM    
Affiliation:
Division of Medical Oncology, Vanderbilt Clinic, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents, Phytogenic / administration & dosage,  therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Clinical Trials as Topic
Forecasting
Humans
Lung Neoplasms / drug therapy*
Paclitaxel / administration & dosage,  therapeutic use
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 33069-62-4/Paclitaxel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Issues in nonoperative management of locally advanced non-small-cell lung cancer.
Next Document:  One-hour paclitaxel plus carboplatin for advanced non-small-cell lung cancer.